Dr. Amer Al Khalifa holds a Ph.D. in Drug Discovery and Development from the Harrison College of Pharmacy at Auburn University. He is currently a postdoctoral fellow at Augusta University, where his research focuses on neurodegenerative diseases, particularly Alzheimer’s disease, with an emphasis on drug discovery and blood–brain barrier integrity. His current work uses human induced pluripotent stem cell (iPSC)-derived models to investigate blood–brain barrier dysfunction and potential therapeutic strategies. With a strong background in pharmacology, pharmacokinetics, and molecular biology, Dr. Al Khalifa integrates in vitro and in vivo models to advance biomedical research.
Dr. Amer Al Khalifa holds a Ph.D. in Drug Discovery and Development from the Harrison College of Pharmacy at Auburn University. He is currently a postdoctoral fellow at Augusta University, where his research focuses on neurodegenerative diseases, particularly Alzheimer’s disease, with an emphasis on drug discovery and blood–brain barrier integrity. His current work uses human induced pluripotent stem cell (iPSC)-derived models to investigate blood–brain barrier dysfunction and potential therapeutic strategies. With a strong background in pharmacology, pharmacokinetics, and molecular biology, Dr. Al Khalifa integrates in vitro and in vivo models to advance biomedical research.